Comments
Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’.
The unique cell culture technology-based vaccine has been developed in collaboration with the Indian Veterinary Research Institute (IVRI), Bareilly.
According to K Anand Kumar, Managing Director, IIL CSF is one of the major diseases of pigs in India and causes a loss of about ₹400 crore per annum in India. The disease has led to a decrease of pig population in the country.
“With the launch of Raksha Class, we can ensure that the pig population in India can be increased and hence, the growers will be immensely benefited economically,’’ he said in a release.
The CSF is a highly contagious viral disease of pigs caused by an RNA virus. This disease has a high fatality rate and therefore, pig growers face serious economic problems with the loss of the herd.
The current requirement is about 22 million doses and the supply is less than a million doses.
The current vaccines manufactured by a few state biologicals depend on the rabbits for vaccine production, where consistency in yields, virus titres, safety and efficacy might not be achieved to the desired levels. IIL’s manufacturing facilities can make several million doses of the vaccine.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.